Effects of elexacaftor / tezacaftor / ivacaftor triple combination therapy on glycaemic control and body composition in patients with cystic fibrosis-related diabetes

Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

Yoav Benjamini, Yosef Hochberg · Journal of the Royal Statistical Society Series B (Statistical Methodology) · 1995 · 108.7K citations

Natural Sciences, Biostatistics, A/b Testing +13

A CFTR Potentiator in Patients with Cystic Fibrosis and the <i>G551D</i> Mutation

Bonnie W. Ramsey, Jane C. Davies, Noel G. McElvaney et al. · New England Journal of Medicine · 2011 · 2.2K citations · Full text

Medicine, Molecular Biology, Molecular Genetics +8

Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr)

E Cacciari, Silvano Milani, Antonio Balsamo et al. · Journal of Endocrinological Investigation · 2006 · 809 citations

Medicine, Child Health, Pediatrics +12

Ivacaftor in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del-CFTR Mutation

Patrick A. Flume, Theodore G. Liou, Drucy Borowitz et al. · CHEST Journal · 2012 · 330 citations · Full text

Life Sciences, Genetics, Molecular Genetics +13

Disease progression in patients with cystic fibrosis treated with ivacaftor: Data from national US and UK registries

Nataliya Volkova, Kristin A. Moy, Jennifer Evans et al. · Journal of Cystic Fibrosis · 2019 · 255 citations

Medicine, Internal Medicine, Pharmacotherapy +14